Soner Yildiz - Concepedia

Author

Soner Yildiz

Icahn School of Medicine at Mount Sinai ORCID

Also Known As

Soner Yildiz, Yildiz Soner, Yildiz, Soner

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Icahn School of Medicine at Mount Sinai University of Geneva University of California, San Francisco Texas Biomedical Research Institute Quantitative BioSciences

About

Soner Yildiz is an author at Icahn School of Medicine at Mount Sinai specializing in immunology, virology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Immunology	6	6	593
2	Medicine	5	5	473
3	Cell Biology	1	1	356
4	Microbiology	1	1	20
5	Pathology	1	1	30

Soner Yildiz

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A Kris M. White, Romel Rosales, Soner Yildiz, Science MedicineViral PathogenesisImmunologyAntiviral ResponseVirology	2021	356
Influenza A virus infection impacts systemic microbiota dynamics and causes quantitative enteric dysbiosis Soner Yildiz, Béryl Mazel‐Sanchez, Matheswaran Kandasamy, Microbiome	2018	281
The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human sera Raveen Rathnasinghe, Sonia Jangra, Anastasija Čupić,	2021	136
TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation Jessica Ho, Bobo Wing-Yee Mok, Laura Campisi, Cell Top1 Inhibition TherapyImmunologyAntiviral ResponseAntiviral Drug Development	2021	120
SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice Emma S. Winkler, Rita E. Chen, Fahmida Alam, Journal of Virology	2021	85
CpG ODN Nanorings Induce IFNα from Plasmacytoid Dendritic Cells and Demonstrate Potent Vaccine Adjuvant Activity Bilgi Gungor, Fuat Cem Yağcı, Gizem Tincer, Science Translational Medicine	2014	78
Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis Thomas Kehrer, Anastasija Čupić, Chengjin Ye, Cell Host & Microbe	2023	73
Phosphoproteomic-based kinase profiling early in influenza virus infection identifies GRK2 as antiviral drug target Emilio Yángüez, Annika Hunziker, Maria Pamela Dobay, Nature Communications	2018	56
Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19 José F. Varona, Pedro Landete, José A. López-Martín, Life Science Alliance	2022	50
Influenza A viruses limit NLRP3‐NEK7‐complex formation and pyroptosis in human macrophages Inês Boal‐Carvalho, Béryl Mazel‐Sanchez, Filo Silva, EMBO Reports Human MacrophagesPathogenesisViral PathogenesisImmunologyVirology	2020	46

Page 1